AZ Pharmaceutical Group Limited
About AZ Pharmaceutical Group Limited
Categories
-
CN
-
2017On CPHI since
Products from AZ Pharmaceutical Group Limited (3)
-
Product DAPTOMYCIN FOR INJECTION, 0.5g
For treatment of bloodstream infection (bacteremia) associated with right infective endocarditis caused by Staphylococcus aureus(including methicillin sensitivity and methicillin resistance).
-
Product DOXOFYLLINE FOR INJECTION, 0.1g
Suitable for Dyspnea due to bronchial asthma, chronic bronchitis and other bronchospasm . -
Product LEVOFLOXACIN MESYLATE FOR INJECTION
strength 0.2g, 0.3g
It suitable for moderate or severe infections caused by sensitive bacterial, including respiratory system infection, acute bronchitis, acute exacerbation of chronic bronchitis, diffuse bacterial bronchitis, bronchiectasis, pneumonia, tonsillitis,etc.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance